5-amino-1mq mechanism nad+ NNMT Inhibitor Injector Pen | Fat-Metabolism & Research Size:1000 mcg/ml - 1 box (10amp. x 1ml) Titan Medical meets with Adson

5-amino-1mq mechanism nad+ NNMT Inhibitor Injector Pen | Fat-Metabolism & Research Size:1000 mcg/ml - 1 box (10amp. x 1ml) Titan Medical meets with Adson

Titan Medical meets with strategic buyers and investors

Interesting about B12 & Canada, I live in the Washington state capital (Olympia, also known as the "South (Puget) Sound" area) area, so definitely within driving range of British Columbia

Adson

Size:1000 mcg/ml - 1 box (10amp. x 1ml)

The pivotal trial supporting its 2010 FDA approval enrolled 816 HIV-infected adults with clinically defined lipodystrophy, and Phase 3 data documented visceral fat reductions of roughly 15-18% over 26 weeks of treatment a result robust enough to clear FDA review for a defined medical indication